Bridgebio Pharma Inc., of Palo Alto, Calif., appointed Ronald J. Daniels to its board.
Chimerix Inc., of Durham, N.C., appointed Pratik S. Multani, M.D., to its board.
Nervgen Pharma Corp., of Vancouver, British Columbia, appointed William Adams chief financial officer.
PDS Biotechnology Corp., of Princeton, N.J., appointed Kamil Ali-Jackson to its board and audit committee.
Renovacor Inc., of Philadelphia, appointed Anne Prener to its board and scientific advisory board.